Success Metrics

Clinical Success Rate
89.7%

Based on 35 completed trials

Completion Rate
90%(35/39)
Active Trials
10(15%)
Results Posted
23%(8 trials)
Terminated
4(6%)

Phase Distribution

Ph phase_2
10
15%
Ph phase_3
7
10%
Ph phase_1
3
4%
Ph phase_4
17
25%
Ph not_applicable
9
13%

Phase Distribution

3

Early Stage

10

Mid Stage

24

Late Stage

Phase Distribution46 total trials
Phase 1Safety & dosage
3(6.5%)
Phase 2Efficacy & side effects
10(21.7%)
Phase 3Large-scale testing
7(15.2%)
Phase 4Post-market surveillance
17(37.0%)
N/ANon-phased studies
9(19.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

35 of 40 finished

Non-Completion Rate

12.5%

5 ended early

Currently Active

10

trials recruiting

Total Trials

67

all time

Status Distribution
Active(12)
Completed(35)
Terminated(5)
Other(15)

Detailed Status

Completed35
unknown15
Recruiting9
Terminated4
Not yet recruiting2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
67
Active
10
Success Rate
89.7%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (6.5%)
Phase 210 (21.7%)
Phase 37 (15.2%)
Phase 417 (37.0%)
N/A9 (19.6%)

Trials by Status

completed3552%
active_not_recruiting11%
terminated46%
unknown1522%
withdrawn11%
recruiting913%
not_yet_recruiting23%

Recent Activity

Clinical Trials (67)

Showing 20 of 67 trialsScroll for more
NCT02850081Phase 3

Statin Neuroprotection and Carotid Endarterectomy: Safety, Feasibility and Outcomes

Terminated
NCT03228238Phase 4

ANti-Oxidant in Variant Angina (ANOVA) Trial

Terminated
NCT07549932Not Applicable

Adjunctive Role of Statin Therapy on Airway Inflammation and Clinical Consequences of Chronic Obstructive Pulmonary Disease

Completed
NCT06553157Phase 1

Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy

Completed
NCT07344610

Effects of Short-term Intensive Statin Therapy on Lipid Levels

Recruiting
NCT06902740Phase 4

PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis

Recruiting
NCT06604117

Efficacy of Probucol Combined with Statins Treatment for Ischemic Stroke

Recruiting
NCT06738758

Multicenter Real-World Cohort Study Evaluating the Impact of Early Intensive Lipid-Lowering Therapy on the Prognosis of Acute Coronary Syndrome Patients(ELITE-ACS)

Recruiting
NCT06280976Phase 4

Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP)

Withdrawn
NCT06785740

Statins in Frail Older Patients with Ischemic Stroke or Transient Ischemic Attack - the Prospective Cohort Study

Recruiting
NCT06730802Not Applicable

Protective Effect of PCSK9 Inhibitor Against Negative Inflammatory Response and Organ Dysfunction After Coronary Artery Bypass Grafting (PANDA VIII)

Not Yet Recruiting
NCT04826237Phase 4

Oral Statins and Protection From Hearing Loss

Recruiting
NCT04369664Phase 4

CHOlesterol Lowering and Residual Risk in Type 2 Diabetes

Completed
NCT06520904Phase 4

Effect of PCSK9 Inhibitors on Coronary Atherosclerotic Plaques Derived From Optical Coherence Tomography

Recruiting
NCT05122780Phase 4

Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial).

Active Not Recruiting
NCT06468254Phase 2

An Exploratory Clinical Study of Statins for Improving Chemotherapy and Maintenance in Patients With Ovarian Cancer

Recruiting
NCT04847752

Study of Predictive Factors Related to Prognosis of Patients With Ischemic Stroke Due to Large-artery Atherosclerosis

Recruiting
NCT05285085

Real World Evidence Study of Statin Use in Brazil

Completed
NCT03882905Phase 3

A Study of SCH 58235 (Ezetimibe) When Added to Ongoing Therapy With a Statin in Participants With Primary Hypercholesterolemia, Known Coronary Heart Disease, or Multiple Cardiovascular Risk Factors (P02173)

Completed
NCT06367322

Statins and Post-ERCP Acute Pancreatitis (Stark Project)

Completed

Drug Details

Intervention Type
DRUG
Total Trials
67